Main Article Content
Saffrone, Ovarian cancer, MAPK, Apoptosis, AKT/mTOR
Study Objectives: Saffron and its main components have been shown to have anti-tumor and anticancer effects in animal studies and human cancer cell cultures. This study aimed to investigate the anti-cancer effects of saffron on human ovarian cancer cells. Methods: Powder of saffron was applied to the HO–8910 cell lines. Cell viability was determined. ELISA test is used to examine the activity of caspase-3 and expression of AIF, gadd153, grp78, caspase 3, bax, bcl-2, wee 1, which are apoptotic pathway’s mediators. Active ERK (p-ERK), active JNK (p-JNK) active AKT (p-AKT), and active mTOR (p-mTOR) were also analyzed by ELISA. Results: Saffron treatment reduced the viability of ovarian cancer cells. Saffron treatment increased activity of caspase 3 and expression of bax, wee 1, gadd153, grp78, and AIF and decreased bcl-2 which is anti-apoptotic protein. Saffron also decreased the activity of p-ERK, p-JNK, p-AKT, and p-mTOR in ovarian cancer cells. Conclusion: This study revealed that saffron has a beneficial effect on cancer treatment. Saffron may show a synergistic effect with various chemotherapeutics while directing the cancer cell to death. Crocetin, one of its active components, has shown a synergistic anti-cancer effect combined with cisplatin. Saffron induced apoptosis via ER stress, AKT/mTOR, and MAPK pathways in the ovarian cancer cell line.
2. Kianbakht S, Mozaffari K. Effects of saffron and its Active Constituents, Crocin and Safranal, on Prevention of Indomethacin Induced Gastric Ulcers in Diabetic and Nondiabetic Rats. J Med Plants 2009;8:30‑8.
3. Hoshyar, R. and H. Mollaei, A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin. Journal of Pharmacy and Pharmacology, 2017. 69(11): p. 1419-1427.
4. Shafiee, M., et al., Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action. Journal of Affective Disorders, 2018. 227: 330-337.
5. Khazdair, M.R., et al., The effects of Crocus sativus (saffron) and its constituents on nervous system: A review. Avicenna J Phytomed, 2015. 5(5): p. 376-91.
6. Abdullaev FI, Espinosa‑Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004;28:426–32.
7. Yao, C., et al., Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity. Onco Targets Ther, 2018. 11: p. 2017-2028.
8. Asil, H., (2018). Safran’ın (Crocus sativus L.) Tıbbi ve Farmakolojik Özellikleri, 1. International Mersin Symposium, Conference Proceedings 2, 145-155.
9. Hoshyar, R., S.Z. Bathaie, and M. Sadeghizadeh, Crocin Triggers the Apoptosis through Increasing the Bax/Bcl-2 Ratio and Caspase Activation in Human Gastric Adenocarcinoma, AGS, Cells. DNA and Cell Biology, 2013. 32(2): p. 50-57.
10. Chen, S., et al., Crocin inhibits cell proliferation and enhances cisplatin and pemetrexed chemosensitivity in lung cancer cells. Transl Lung Cancer Res, 2015. 4(6): p. 775-83.
11. Samarghandian S, Borji A, Farahmand SK, Afshari R, Davoodi S. Crocus sativus L. (Saffron) Stigma Aqueous Extract Induces Apoptosis in Alveolar Human Lung Cancer Cells through Caspase-Dependent Pathways Activation. Biomed Res Int 2013; 2013:1-12.
12. Çıtak EÇ. 2000. "Apoptosis and cancer". Turkiye Klinikleri J Pediatr, 9(3),183-91.
13. Yazıcı P, Alizadehshargh S, Akdoğan GG. 2009." Apopitoz: Düzenleyici Moleküller, hastalıklarla İlişkisi ve Apopitozu Saptama Yöntemleri." Turkiye Klinikleri J Med Sci, 29(6),1677-86.
14. Call JA, Eckhardt SG, Camidge DR. "Targeted manipulation of apoptosis in cancer treatment. Lancet Oncol," 2008; 9(10):1002.
15. Heiser D, Labi V, Erlacher M, Villunger A. "The Bcl-2 protein family and its role in the development of neoplastic disease." ExpGerontol, 2004; 39(8): 1125-35.
16. Mousavi S.H., Tavakkol-Afshari J., Brook A., Jafari-Anarkooli I. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food and Chemical Toxicology 2009;47:1909-1913.
17. Berek, J.S., Natarajan S., Ovarian and Fallopian Tube Cancer, Berek& Novak's Gynecology, Lippincott William &Wilkins 2007. 14th edition, p1457-1548.
18. Kathawala R.J., Kudelka A., Rigas B. The Chemoprevention of Ovarian Cancer: the Need and the Options. Current Pharmacol Rep. 2018;4(3): 250-260. DOI: 10.1007/s40495-018-0133-6.
19. Hoshyar, R. and H. Mollaei, A comprehensive review on anticancer mechanisms of main carotenoid of saffron, crocin. Journal of Pharmacy and Pharmacology, 2017. 69(11): 1419-1427.
20. Moradzadeh, M., et al., Anti-tumor effects of crocetin and related molecular targets. Journal of Cellular Physiology, 2018. 233(3): p. 2170-2182.
21. Wang, W.A., J. Groenendyk, and M. Michalak, Endoplasmic reticulum stress associated responses in cancer. Biochimica Et Biophysica Acta-Molecular Cell Research, 2014. 1843(10): p. 2143-2149.
22. Dhillon, A.S., et al., MAP kinase signalling pathways in cancer. Oncogene, 2007. 26(22): p. 3279-3290.
23. Germann, U.A., et al., Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib). Molecular Cancer Therapeutics, 2017. 16(11): p. 2351-2363.
24. Aziz, A.U.R., et al., PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer. Biomolecules, 2018. 8(1).
25. Amin, A., et al., Saffron: A Potential Candidate for a Novel Anticancer Drug against Hepatocellular Carcinoma. Hepatology, 2011. 54(3): p. 857-867.